|Articles|February 15, 2023
- Applied Clinical Trials-02-01-2023
- Volume 32
- Issue 1/2
Applied Clinical Trials January/February 2023 Issue (PDF)
Click the title above for a link to open the Applied Clinical Trials January/February 2023 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 2 years ago
The Benefits and Limitations of Clinical Data Platformsover 2 years ago
Progress Report: Pharma Adoption of Data Analyticsover 2 years ago
FDA Interactions With Industry Under the Microscopeover 2 years ago
2023 SCOPE: It’s an Orlando Thingalmost 3 years ago
Get it Right Next Time? EU Legislation Under Critical Reviewalmost 3 years ago
Advances in eSource Interoperability Between EHR and EDCalmost 3 years ago
Identifying Patient NeedsNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: AI, Caplyta Approval, and FDA Priority Vouchers
2
Bezuclastinib Plus Sunitinib Achieves Strong PFS Benefit in Phase III PEAK Trial for Imatinib-Resistant GIST
3
Scaling Recruitment Across Therapeutic Areas and Regions
4
Evolving Trial Designs Advance Precision Medicine Through Basket, Umbrella, and Platform Models
5



.png)



.png)



.png)
.png)
